Literature DB >> 21927890

Looking after silent coronary artery disease in diabetic patients. When and how?

Paul Valensi.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21927890     DOI： 10.1007/s12020-011-9534-6

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  9 in total

1.  Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

Authors:  E Cosson; F Paycha; J Paries; S Cattan; A Ramadan; D Meddah; J-R Attali; P Valensi
Journal:  Diabet Med       Date:  2004-04       Impact factor: 4.359

Review 2.  Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature.

Authors:  Paul Valensi; Luc Lorgis; Yves Cottin
Journal:  Arch Cardiovasc Dis       Date:  2011-03-26       Impact factor: 2.340

3.  Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group.

Authors: 
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

4.  Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Adriana Garzaniti; Gabriele Pelissero; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Colomba Falcone; Sebastiano B Solerte; Andrea Giustina
Journal:  Endocrine       Date:  2011-08-23       Impact factor: 3.633

Review 5.  It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia.

Authors:  P Valensi; E Cosson
Journal:  Diabetes Metab       Date:  2010-02-26       Impact factor: 6.041

6.  Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors.

Authors:  P Fornengo; A Bosio; G Epifani; O Pallisco; A Mancuso; C Pascale
Journal:  Diabet Med       Date:  2006-07       Impact factor: 4.359

7.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Authors:  Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

8.  Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.

Authors:  A Nitenberg; P Valensi; R Sachs; M Dali; E Aptecar; J R Attali
Journal:  Diabetes       Date:  1993-07       Impact factor: 9.461

9.  Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients.

Authors:  Emmanuel Cosson; Minh Tuan Nguyen; Bernard Chanu; Isabela Banu; Sabrina Chiheb; Cristina Balta; Karim Takbou; Paul Valensi
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112
  9 in total
  1 in total

1.  Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Arturo Pujia; Colomba Falcone; Silvia Collaviti; Mariangela Fodaro; Pietro Gallotti; Sebastiano B Solerte; Andrea Giustina; Gabriele Pelissero; Livio Luzi; Tiziana Montalcini
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.